semaglutide and colon cancer How May Reduce The Risk Of Obesity-Linked Cancers GLP-1 Weight-Loss Meds Linked to

GLP-1 agonists like semaglutide (brand names Wegovy and Ozempic) and tirzepatide (brand names Mounjaro and Zepbound) have revolutionized obesity treatment

For patients with cardiovascular disease but not chronic kidney disease, SGLT-2 inhibitors reduce overall mortality with an NNT of 39 (95% CI, 27 to 72) over five years

Although there are controversial studies [17], age may be a contributor as older people have higher risks of diabetes and depression, possibly because of physical limitations and other health problems [18]

Basal insulin and GLP-1 combinations, or fixed-ratio combination drugs, promise to do just that: maximize the benefits and minimize the side effects someone might experience taking each drug separately